151 related articles for article (PubMed ID: 329629)
1. PHA dose dependent defect in lymphocyte stimulation and E-rosette-forming cells in untreated Hodgkin's disease.
Land JM; Litwin J; Bigel P; Oberling F; Mayer S
Acta Haematol Pol; 1977; 8(2):131-4. PubMed ID: 329629
[TBL] [Abstract][Full Text] [Related]
2. [Hodgkin's disease. T lymphocyte defect in patients in complete remission (author's transl)].
Lang JM; Bigel P; Oberling F; Mayer S
Pathol Biol (Paris); 1978; 26(3-4):159-62. PubMed ID: 355984
[TBL] [Abstract][Full Text] [Related]
3. [Hodgkin's disease. T lymphocyte defect in patients in complete remission (author's transl)].
Lang JM; Bigel P; Oberling F; Mayer S
Sem Hop; 1978 Nov 8-15; 54(37-40):1155-8. PubMed ID: 217096
[TBL] [Abstract][Full Text] [Related]
4. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.
Matchett KM; Huang AT; Kremer WB
J Clin Invest; 1973 Aug; 52(8):1908-17. PubMed ID: 4541673
[TBL] [Abstract][Full Text] [Related]
5. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
[TBL] [Abstract][Full Text] [Related]
6. Reversal of cell surface abnormalities of T lymphocytes in hodgkin's disease after in vitro incubation in fetal sera.
Fuks Z; Strober S; King DP; Kaplan HS
J Immunol; 1976 Oct; 117(4):1331-5. PubMed ID: 1086325
[TBL] [Abstract][Full Text] [Related]
7. Lymphocyte function in patients with Hodgkin's disease.
Rühl H; Vogt W; Rühl U
G Batteriol Virol Immunol; 1975; 68(1-6):3-16. PubMed ID: 128484
[TBL] [Abstract][Full Text] [Related]
8. A micro-method for PHA-induced stimulation of human lymphocytes. II. communication: effect of splenectomy on the inhibitory activity of serum in patients with Hodgkin's disease.
Pappas A; Pees H; Girmann G
Z Immunitatsforsch Immunobiol; 1977 Apr; 153(1):1-10. PubMed ID: 868205
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors in Hodgkin's disease. II. Role of the lymphocyte defect.
Björkholm M; Holm G; Mellstedt H; Johansson B; Killander D; Sunblad R; Söderberg G
Scand J Haematol; 1978 Apr; 20(4):306-18. PubMed ID: 653310
[TBL] [Abstract][Full Text] [Related]
10. Lymphocyte reactivity to phytohaemagglutinin and allogeneic lymphocytes in 32 untreated patients with Hodgkin's disease.
Lang JM; Oberling F; Bigel P; Mayer S; Waitz R
Biomedicine; 1974 Sep; 21(9):372-7. PubMed ID: 4281669
[No Abstract] [Full Text] [Related]
11. Quantitation of immunocompetence in Hodgkin's disease.
Faguet GB
J Clin Invest; 1975 Oct; 56(4):951-7. PubMed ID: 1159096
[TBL] [Abstract][Full Text] [Related]
12. [Cellular immunity in patients with Hodgkin's disease: modification induced by incubating lymphocytes with fetal calf serum and Hodgkin's serum].
Rambotti P; Velardi A; Spinozzi F; Falini B; Martelli MF
Boll Ist Sieroter Milan; 1979 Mar; 58(1):90-9. PubMed ID: 552840
[TBL] [Abstract][Full Text] [Related]
13. [Case of implantation of human fetal thymus on the immunological reactivity in patients with Hodgkin's disease].
Pekić B; Dujić A; Radojicić B; Radojicić C; Kolasinović N; Martinović N; Susaković N; Radovanović L
Bilt Hematol Transfuz; 1975; 3(1-2):105-19. PubMed ID: 1225309
[TBL] [Abstract][Full Text] [Related]
14. Mixed lymphocyte culture stimulatory and responding capacity of lymphocytes from patients with lymphoproliferative diseases.
Rühl H; Vogt W; Bochert G; Schmidt S; Moelle R; Schaoua H
Clin Exp Immunol; 1975 Jan; 19(1):55-65. PubMed ID: 128426
[TBL] [Abstract][Full Text] [Related]
15. Radiosensitivity of Hodgkin's disease lymphocytes.
Baral E; Blomgren H; Rotstein S
J Clin Lab Immunol; 1981 Mar; 5(2):101-5. PubMed ID: 7218327
[TBL] [Abstract][Full Text] [Related]
16. In vitro responses of peripheral blood and spleen lymphoid cells to mitogens and antigens in childhood Hodgkin's disease.
Tan CT; de Sousa M; Tan R; Hansen JA; Good RA
Cancer Res; 1978 Apr; 38(4):886-93. PubMed ID: 346206
[TBL] [Abstract][Full Text] [Related]
17. Monocyte PGE2 secretion in Hodgkin's disease and its relation to decreased cellular immunity.
Passwell J; Levanon M; Davidsohn J; Ramot B
Clin Exp Immunol; 1983 Jan; 51(1):61-8. PubMed ID: 6572580
[TBL] [Abstract][Full Text] [Related]
18. Comparative studies of the proportions of T, B and zero lymphocytes and the degrees of blastic transformation of lymphocytes after stimulation by PHA and CON A in patients with Hodgkin's disease.
Pluzańska A
Haematol Blood Transfus; 1977; 20():203-7. PubMed ID: 305396
[No Abstract] [Full Text] [Related]
19. Autologous rosette-forming capacity of T-lymphocytes in Hodgkin's disease.
Bodolay E; Berényi E; Sonkoly I; Szegedi G
Acta Med Hung; 1984; 41(2-3):113-9. PubMed ID: 6611543
[TBL] [Abstract][Full Text] [Related]
20. Impaired lymphocyte function in untreated Hodgkin's disease.
Levy R; Kaplan HS
N Engl J Med; 1974 Jan; 290(4):181-6. PubMed ID: 4203007
[No Abstract] [Full Text] [Related]
[Next] [New Search]
